New research reveals the true scope of COVID-19’s global spread. But don’t bank on herd immunity.
How can we make our financial system less fragile? How can we make our healthcare infrastructure less reactive? What can we do to create more robust civic institutions that work for all of us?
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
On May 1-3, 2020, MIT will host the Africa Takes on COVID-19 Challenge. The deadline to apply for participation is Tuesday, April 28, 2020 before midnight.
The latest working papers from MIT Sloan faculty about the coronavirus/COVID-19 pandemic.
Prof. Dimitris Bertsimas and nearly two dozen doctoral students are using machine learning and optimization to find answers and generating accurate real-time insight into the pandemic.
Managing in a pandemic requires knowledge and foresight. These articles examine what’s next for the economy, remote work, and an innovative vaccine.
MIT Sloan School Prof. Emil Verner analyzed the economic effects of the 1918 Flu Pandemic and found that public health interventions have no adverse effect on local economic outcomes.
Moderna’s CEO explains how the firm fast-tracked COVID-19 vaccine development, and how a public-private partnership could make future work even faster.
Hospitals are becoming overwhelmed with COVID-19 cases. Here are four ways telemedicine can remake the triage process to better manage patient flow.
